NEULASTA/NEUPOGEN
FIRST STEP™ Program Registration


Welcome to the NEULASTA/NEUPOGEN FIRST STEP™ Program.

Please complete the online form below to register your card.

If you have any questions or problems using your card after registration, please call 1-888-65-STEP1 (1-888-657-8371) from 9 a.m. to 8 p.m. ET, Monday-Friday.


ENTER CARD INFORMATION: STEP 1 OF 2


* Required Data

Please select product prescribed:
  • Neulasta®
  • NEUPOGEN®
* Enter the last 4 digits of the 16-digit MasterCard number that appears in the middle of the card:
* Please type in the 7 or 8 digit Card number that appears on the bottom left of your card after the letters NL:
Are you a resident of one of the 50 United States or Puerto Rico?
  • Yes
  • No
*Date of Birth (for verification): (DD-MM-YYYY):
Do you belong to or have prescriptions paid for by any: i) federal government-funded healthcare program, such as Medicare, Medicare Advantage, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD) or TRICARE, or ii) any similar state-funded program such as a state pharmacy assistance program?
  • Yes
  • No
The Amgen FIRST STEP Program is not valid for patients who belong to any federal, state or government-funded healthcare program and you must have commercial or private healthcare insurance to be eligible for this program. Should you at any time begin receiving health insurance under such a federal, state or government-funded healthcare program, you will no longer be eligible to participate in the Amgen FIRST STEP Program. Do you agree with this statement?
  • Yes
  • No
Do you have commercial or private healthcare insurance?
  • Yes
  • No
Are you a patient who is enrolled in a plan offered through the Health Insurance Exchanges?
  • Yes
  • No

Indication

Neulasta® (pegfilgrastim) and NEUPOGEN® (filgrastim) are prescription medications used to reduce the risk of infection (initially marked by fever) in patients with some tumors receiving strong chemotherapy that decreases the number of infection-fighting white blood cells.

Your doctor will do blood tests to monitor your blood cell counts before and during your treatment with NEUPOGEN®.

Important Safety Information

Do not take Neulasta® or NEUPOGEN® if you have had an allergic reaction to Neulasta® (pegfilgrastim) or to NEUPOGEN® (filgrastim).

Neulasta® or NEUPOGEN® may reduce your chance of getting an infection, but it does not prevent all infections. An infection can happen anytime your neutrophil counts are low. Look for signs of infection, such as fever, chills, rash, sore throat, diarrhea, or redness, swelling, or pain around a cut or sore. If you have any of these signs, contact your health care professional immediately.

Your spleen may become enlarged and can rupture while taking Neulasta® or NEUPOGEN®. A ruptured spleen can cause death. The spleen is located in the upper left section of your stomach area. Call your doctor right away if you have pain in the left upper stomach area or left shoulder tip area. This pain could mean your spleen is enlarged or ruptured.

A serious lung problem called acute respiratory distress syndrome (ARDS) has been reported with Neulasta® and NEUPOGEN® use. Call your doctor or seek emergency care right away if you have shortness of breath, trouble breathing, or a fast rate of breathing.

Neulasta® and NEUPOGEN® can cause serious allergic reactions. These reactions can cause shortness of breath, wheezing, dizziness, swelling around the mouth or eyes, fast pulse, sweating, and hives. If you start to have any of these symptoms, call your doctor or seek emergency care right away. If you have an allergic reaction during the injection, stop the injection. Call your doctor right away.

You may have a serious sickle cell crisis if you have a sickle cell disorder and take Neulasta® or NEUPOGEN®. Serious and sometimes fatal sickle cell crises can occur in patients with sickle cell disorders receiving NEUPOGEN®. Call your doctor right away if you have symptoms of sickle cell crisis such as pain or difficulty breathing.

Talk to your doctor if you experience unusual bleeding or bruising while taking NEUPOGEN®, as this could mean a decrease of platelets which reduces the ability of blood to clot.

The most common side effect you may experience is aching in the bones and muscles. If this happens, it can usually be relieved with a nonaspirin pain reliever, such as acetaminophen.

Some people experience redness, swelling, or itching at the site of injection. If you notice any signs of a local reaction, call your doctor.

If you have any questions about this information, be sure to discuss them with your doctor. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.

For more information about Neulasta® (pegfilgrastim), please see Neulasta® Prescribing Information. For more information about NEUPOGEN® (filgrastim), please see NEUPOGEN® Prescribing Information.